Julian Hanson InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Julian Hanson, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Biologics.

Product Description

This InspectorProfile report is updated through May 2022 and lists Julian Hanson's inspections in 13 countries: United States, Netherlands, Germany, Hungary, Austria, Spain, United Kingdom, Italy, Poland, France, Israel, India, and Canada.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Julian Hanson's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Julian Hanson.

Product details

• Julian Hanson's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Julian Hanson has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Michelle Hines, Mendoza Wallace, Hugh Mcclure, Mark Seaton, Tawny Colling, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.